CDK6 and neoplasm: Hsa_circ_000984 acts as a competing endogenous RNA (ceRNA) by competitively binding to miR-106b and effectively upregulating CDK6 expression, thereby inducing a series of malignant phenotypes of tumor cells (Xu et al., 2017).